Cargando…
Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type, characterized by a dismal prognosis due to late diagnosis, frequent metastases, and limited therapeutic response to standard chemotherapy. Circulating tumor cells (CTCs) are a rare subset of tumor cells found in the...
Autores principales: | Yeo, Dannel, Bastian, Althea, Strauss, Heidi, Saxena, Payal, Grimison, Peter, Rasko, John E. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836025/ https://www.ncbi.nlm.nih.gov/pubmed/35163592 http://dx.doi.org/10.3390/ijms23031671 |
Ejemplares similares
-
Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging
por: Yeo, Dannel, et al.
Publicado: (2023) -
The next wave of cellular immunotherapies in pancreatic cancer
por: Yeo, Dannel, et al.
Publicado: (2022) -
Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
por: Castelletti, Laura, et al.
Publicado: (2021) -
Hitting the Bull’s-Eye: Mesothelin’s Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma
por: Yeo, Dannel, et al.
Publicado: (2021) -
Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer
por: Takai, Erina, et al.
Publicado: (2015)